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ScienceDirectOver the last five decades more than 100 types of RNA
modifications have been identified in organism of all
kingdoms of life, yet their function and biological relevance
remain largely elusive. The recent development of
transcriptome-wide techniques to detect RNA modifications
such as N6-methyladenosine (m6A) and 5-methylcytidine
(m5C) has not only created a new field of research ‘the
epitranscriptome’ but also featured essential regulatory roles
of RNA methylation in a wide range of fundamental cellular
processes. Here, we discuss the current knowledge of m6A
and m5C RNA methylation pathways and summarize
how they impact normal tissues and contribute to human
disease.
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Introduction
Post-transcriptional  regulation of gene expression
ultimately determines the rate of protein translation
and is therefore crucial for virtually all cellular pro-
cesses. Post-transcriptional  modifications add complex-
ity to RNA-mediated functions by regulating how
and when a primary RNA transcript is converted
into mature RNA. There are around 150 known
RNA modifications [1], yet our knowledge about their
occurrence and function in RNA is still very limited.
The existence of methylated bases in RNA including
C5-methylcytidine (m5C) and N6-methyladenosine
(m6A) has been described 50 years ago [2]. However,
until only very recently, m5C for instance was thought
to be mainly restricted to the stable and highly abun-
dant transfer RNAs (tRNAs) and ribosome RNAs
(rRNAs) [3].www.sciencedirect.com The recent development of novel transcriptome-wide
approaches to capture global m5C and m6A RNA methy-
lomes has not only restored scientific interest in the field
but also contributed to a better understanding how gene
expression is regulated at different levels. In only a couple
of years it became evident that post-transcriptional meth-
ylation of both cytosines and adenosines regulate funda-
mental cellular processes that are essential for normal
development. The importance of a tightly controlled
deposition of both m5C and m6A into RNA is further
underscored by the strong link of loss-of-function
mutations in methylating and demethylating enzymes
to several severe human diseases.
Post-transcriptional 5-methylcytidine
Over the last years, several methods have been developed
to globally detect 5-methylcytidine in RNA. Bisulfite
sequencing was first adapted for detecting m5C in
RNA and confirmed that m5C can be reproducibly and
quantitatively detected in tRNA and rRNA (Figure 1a
and b) [4]. RNA bisulfite conversion in combination with
next generation sequencing further identified m5C in
both coding and non-coding RNAs in addition to tRNAs
and rRNAs [5,6]. One limitation of RNA bisulfite se-
quencing is that ideally the data need to be compared to
cells lacking the specific RNA methyltransferases to
confirm the signals. Indeed, only a small fraction of
methylated RNAs identified by bisulfite sequencing
overlapped with the specific RNA targets of the cyto-
sine-5 RNA methylases Dnmt2 and NSun2 [3].
Two recently developed methods based on RNA immu-
noprecipitation approaches followed by next generation
sequencing identified Dnmt2- and NSun2-specific RNA
methylation targets [7,8]. In spite of all system-wide
approaches, Dnmt2-mediated methylation seems to be
restricted to only three tRNAs: GlyGCC, AspGTC and
ValAAC [8,9,10]. The vast majority of NSun2-mediated
methylation was found in a wide range of tRNAs, but in
addition NSun2 also targeted other non-coding and a
small number of coding RNAs [7,8]. Among the
non-coding RNAs, NSun2 consistently methylated vault
RNAs [7]. Hypomethylation of vault RNA at NSun2-
mediated sites altered its processing patterns into small
microRNA like molecules that can bind to Argonautes
and regulate mRNAs [7].
NSun2-mediated methylation of mRNAs remains enig-
matic. Synthetic cytosine-5 methylated mRNAs can be
more stable and loss of NSun2-mediated methylation inCurrent Opinion in Cell Biology 2014, 31:1–7
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Regulation and function of RNA methylation. C5-methylcytidine (m5C) is a common modification in (a) tRNAs and (b) other non-coding RNAs (ncRNAs).
NSun2, NSun4 and Dnmt2 can catalyze methylation of cytosine-5 but no m5C-demethylases have been reported yet (a and b). (c) N6-methyladenosine
(m6A) is an abundant internal modification in mRNA. Its deposition is dynamically regulated by methylases (Mettl3 and Mettl14) and demethylases (Fto
and AlkBH5). Accurate and adequate methylation levels dictate the fate, processing, interaction with ‘readers’ (YTHDF, HUR) and further function of
methylated RNAs. All reported molecular functions relate to the regulation of transcriptional and translational processes.the 30UTR of p16 has been reported to reduce its stability
[11]. Yet we have shown recently that virtually none of
the mRNAs potentially methylated by NSun2 changed in
abundance in NSun2 depleted cells [7].
Biological roles of cytosine-5 RNA methylases
RNA m5C methyltransferase belong to a large and highly
conserved group of proteins, yet their RNA substrate
specificity is predicted to be different [12]. Pioneering
work in single cell organisms shed light on the enzymatic
formation as well as the molecular and biological func-
tions of m5C in RNA and is reviewed elsewhere. For
space reasons, we will focus on the biological roles of m5C
methyltransferases in multicellular organisms.
The DNA methyltransferase homolog Dnmt2
Among all RNA methyltransferases Dnmt2 is the
best studied, yet mostly for its potential function inCurrent Opinion in Cell Biology 2014, 31:1–7 methylating DNA. Dnmt2 shares almost all sequence
and structural features of DNA methyltransferases [13].
However, over the last years it became evident that
Dnmt2 plays no major role in influencing global DNA
methylation. Dnmt2-deficient mouse embryonic stem
(ES) cells do not display altered genomic methylation
patterns and organisms expressing only Dnmt2 as the sole
candidate DNA methyltransferase gene lack genomic
methylation patterns [14,15].
Dnmt2 was one of the first cytosine-5 RNA methylases
identified in a multicellular organism [16]. Although
Dnmt2-mediated methylation of cytosine 38 in the antic-
odon loop of tRNAAsp was conserved in plant, flies and
mice, none of these organisms lacking the functional
Dnmt2 protein displayed any morphological differences
to their wild-type counterparts [16]. In contrast, mor-
pholino-mediated loss of Dnmt2 in zebrafish reduced thewww.sciencedirect.com
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liver, retina and brain development due to a failure to
conduct late differentiation [17]. Over-expression of
Dnmt2 on the other hand prolonged the life span of
Drosophila by more than 50% and increased the resistance
to stress [18]. In line with these studies, Drosophila Dnmt2
loss-of-function mutants showed reduced viability under
stress conditions, and Dnmt2-mediated methylation pro-
tected tRNAs from stress-induced ribonuclease cleavage
(Figure 1a) [9].
Cleavage of tRNAs is a conserved response to several
stress stimuli in eukaryotes and the tRNA fragments are
produced to repress translation by displacing translation
initiation and elongation factors from mRNAs or by
interfering with efficient transpeptidation [19–21]. How-
ever, whether and how increased tRNA cleavage in
Drosophila Dnmt2 mutants is directly linked to stress
tolerance and protein translation is currently unknown.
While tRNA cleavage is mediated by angiogenin in
mammals, the only identified tRNA nuclease in Droso-
phila so far is Dicer [22]. Interestingly, also expression of
Dicer is down-regulated by oxidative stress and Dicer
knockout cells can be hypersensitive towards oxidative
stress whereas its over-expression confers stress resistance
[23]. Other functions that have been linked to Dnmt2 but
may be independent of its tRNA methyltransferase
activity are silencing of retro-transposons and control of
RNA viruses in Drosophila as well as RNA-mediated
paramutations in the mouse [24]. Together, these data
implicate that Dnmt2 is functionally redundant for nor-
mal development of most multicellular organisms but
implicated in cellular stress responses at least in adult
flies [24].
The NOP2/Sun (NSun) RNA methyltransferase
family
At least two more enzymes NSun2 and NSun4 can gen-
erate 5-methylcytidine in RNA in mammals (Figure 1a
and b) [25,26]. Both belong to the S-Adenosylmethionine
(AdoMet)-dependent methyltransferase superfamily and
at least five more putative m5C RNA methylases in
mammals (NOP2, NSun3, and NSun5–7) are predicted
to methylate RNA based on sequence conservation of key
catalytic residues [12]. Although the substrate specifici-
ties are unknown, NSun1 and NSun5, in addition to
NSun2 and Nsun4, have been identified as mRNA-bind-
ing proteins [27]. The biological functions of most mem-
bers of the NSun-protein family is largely unknown,
although all of them are expressed during mouse embry-
ogenesis and NSun2–7 are all enriched in the developing
brain [28].
NSun2 was first described in the mammalian epidermis as a
transcriptional target of the proto-oncogene c-Myc [25].
NSun2 is up-regulated in a wide range of cancers and
knockdown of NSun2 in human squamous-cell-carcinomawww.sciencedirect.com xenografts decreased their growth [25,29]. NSun2 is a
nucleolar protein that is regulated by Aurora B kinase
and promotes cell division by stabilizing the mitotic spin-
dle in cancer cell lines, yet this function seems indepen-
dent of its methyltransferase activity and has yet to be
confirmed in vivo [30,31].
Interestingly, deletion of NSun2 in mice caused a phe-
notype resembling deletion of Dnmt2 in zebrafish.
NSun2 knockout mice are smaller than their littermates
and late differentiation is delayed or blocked in specific
tissues including skin and testis [32,33]. In humans,
several genetic mutations in the NSUN2 gene have been
identified and primarily cause autosomal-recessive intel-
lectual disability and a Dubowitz-like syndrome
[34,35,36]. The common symptoms of the disorder in-
clude growth and mental retardation, unusual faces, and
cutaneous abnormalities [34,35,36]. Whether and how
loss of RNA methylation is the underlying cause of all the
symptoms of these complex diseases is currently
unknown. However, similar to the human syndrome,
deletion of the NSun2 ortholog in Drosophila caused
severe short-term-memory deficits [35]; and simultaneous
deletion of Dnmt2 and NSun2, which abrogates all tRNA
methylation, specifically affected brain, liver, and adipose
tissue development due to impaired differentiation pro-
grams [10].
NSun4 functions in mitochondria where it methylates a
single cytosine (C911) of the mtDNA encoded 12S
rRNA [26]. In contrast to deletion of NSun2, germline
deletion of NSun4 is lethal and embryos at E8.5 are
severely growth retarded and lack visible discernible
anatomical structures [26]. Conditional deletion of
NSun4 in the heart caused cardiomyopathy and respir-
atory chain deficiency due to impaired assembly of
mitoribosomes and inhibition of mitochondrial trans-
lation [26].
The biological functions and targeted RNA species of
NSun5 are unknown, yet its yeast homolog Rcm1 has
been reported to target 25S rRNA [37]. In humans the
NSun5 gene is located to a genomic region deleted in
patients with Williams–Beuren syndrome, a rare neuro-
developmental disorder and lack of NSun5 may contrib-
ute to the growth retardation, the myopathy or the
premature aging effects reported for the syndrome [38].
Mutations in the NSUN7 gene has been linked to infer-
tility in mice and human due to impaired sperm motility
[39,40].
NOP2 (NSun1) is nucleolar protein that binds to 60–80S
pre-ribosomal particles and is mainly described for its
function in regulating cell proliferation and is up-
regulated in response DNA damaging agents [41,42].
Whether NOP2 methylates ribosomal RNA has yet to
be confirmed. NOP2 is located in a genomic regionCurrent Opinion in Cell Biology 2014, 31:1–7
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includes a high-pitched cat-like cry, mental retardation,
and microcephaly [43]. The biological functions of
NSun3 and NSun6 proteins are unknown.
In summary, although the precise molecular and bio-
logical functions of RNA m5C methyltransferases are still
poorly understood some commonalities are emerging. A
conspicuously high number of NSun-proteins are associ-
ated with human disease syndromes that include growth
retardation and neurological deficits. This specific link to
human diseases may be explained by a direct role of 5-
methylcytidine in rRNA and tRNA to regulate global
protein translation. Protein synthesis pathways are
coupled to cell size, which may explain the small statue
described for many organisms lacking RNA methyltrans-
ferases. Another commonality is that in the absence of
RNA methylases, the affected organs are often brain and
testis, which both have been described to be the most
susceptible organs to altered protein translation rates
[44,45].
Post-transcriptional N6-methyladenosine
m6A is thought to be the most abundant internal modi-
fication in mRNA (Figure 1c) [46]. The detection of m6A
was long challenging because of the inert chemical reac-
tivity of the methyl group and the fact that this modifi-
cation does not change base-pairing properties or inhibit
reverse transcription. Recently, two independent groups
determined the occurrence of m6A system-wide using
RNA-immunoprecipitation methods followed by next
generation sequencing [47,48]. m6A was found in
more than 7000 mRNAs and over 200 long non-coding
RNAs (lncRNAs), and the conserved most pronounced
location of this modification was in stop codons, 30UTRs
and long internal exons in human, mouse and yeast
[47,48,49]. The consensus sequence is RRm6ACH
(R = A/G and H = A/C/U), yet additionally RNA structure
or RNA binding proteins are likely to be involved in
determining the methylation sites [49]. The occurrence
of m6A-methylation is highly dynamic, and both the
fraction of modified RNAs and distribution of the modi-
fication within RNAs can vary depending on cell types,
tissues and stress conditions [47,48,50].
The addition of a single methyl group to adenosines does
not perturb Watson–Crick base pairing, but it weakens
RNA secondary structure [51]. Thus, the molecular role
of m6A is thought to relate to various aspects of mRNA
metabolism, including mRNA expression and degra-
dation, splicing, translational regulation and regulation
of microRNA-binding [46]. Notably, with the exception
of m6A regulating RNA-protein interactions, there is
currently a considerable lack of evidence supporting other
proposed functions in vivo. The presence of m6A in
mRNA modulates the binding affinity to the RNA bind-
ing proteins Hu-antigen R (HUR) and YTHDF1–3,Current Opinion in Cell Biology 2014, 31:1–7 which in turn regulate the stability and cellular distri-
bution of the bound mRNA [47,52,53].
Considering the high abundance of m6A in a large number
of mRNAs, it is not surprising that this modification has
been implicated in a wide range of cellular processes, and
is likely to play an essential role in development and
tissue differentiation by modulating cell fate and survival,
stress responses, meiosis, the circadian clock, as wells as
cellular immunity [47,49,52,54–56].
Biological roles of N6-methyladenosine RNA
methylases
A not yet fully characterized multicomponent complex
catalyzes the formation of m6A in mammals. The two
methylases methyltransferase-like 3 (Mettl3, also known
as MT-A70) and methyltransferase-like 14 (Mettl14)
form the core of the complex and associate with additional
regulatory factors such as WTAP (Wilm’s tumour 1
associating protein) (Figure 1c) [52,57].
The precise biological functions of m6A-methyltransfer-
ases are not fully understood but emerging evidence
implicates a role in embryo development, gametogenesis
and stem cell self-renewal. Mouse ES cells lacking Mettl3
and Mettl14 lost self-renewal capability and the
decreased levels of m6A in mRNAs of developmental
regulators correlated with binding of the mRNA stabilizer
HUR, indicating that m6A methylation inversely corre-
lated with mRNA stability and is needed to maintain
pluripotency [52]. During embryo development expres-
sion Mettl3 is temporarily controlled, and inactivation of
the plant homolog leads to cell division defects and
embryo development failure [58]. In adult flies, Mettl3
expression is highest in reproductive organs and regulates
gametogenesis [59].
Biological roles of N6-methyladenosine RNA
demethylases
Similar to DNA m5C-methylation, also RNA m6A-meth-
ylation can be reverted. Fat mass and obesity associated
protein (Fto) and a-ketoglutarate-dependent dioxygen-
ase alkB homolog 5 (AlkBH5) are demethylases that
remove m6A from RNA (Figure 1c) [50,54]. Yet, the
only subtle changes in the level of m6A in RNA after Fto
or AlkBH5 over-expression indicated substrate specificity
and suggests the existence of additional demethylating
enzymes [54,60].
Genome-wide association studies linked common poly-
morphisms in the first intron of FTO to body mass index,
risk of obesity, type 2 diabetes, polycystic ovary syndrome
and cardiovascular diseases [61]. Studies in Fto loss-of-
function or gain-of-function mice suggest that the main
mechanism by which Fto predisposes to obesity and
metabolic syndrome is driven by obesity-prone behaviors
such as increased food intake and preference for highwww.sciencedirect.com
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inactivation in mice increased methylation of mRNAs
encoding components of the dopamine signaling pathway
and consequently the dopaminergic reward circuitry sig-
naling was reduced [60]. Other human neurological con-
ditions that have been linked to genetic variations in
FTO include reduced brain volume, increased cognitive
decline in elderly, dementia, Alzheimer’s disease, atten-
tion deficit disorder in children and depression [64].
In addition, FTO polymorphisms in intron 1 have been
linked to a range of human cancers, yet a recent meta-
analysis study suggested that except for pancreatic cancer
the increased cancer risk is rather associated to obesity
than the FTO polymorphism itself [65]. Other poly-
morphisms such as in intron 8 of the FTO gene has been
linked to an increased risk of developing melanoma [66].
While the functional consequences of single nucleotide
polymorphisms in the intronic region of FTO are still
unknown, loss-of-function mutations of FTO in humans
lead to an autosomal-recessive lethal syndrome of severe
growth retardation, microcephaly, psychomotor delay,
cardiac deficits, and multiple malformations, and at least
some of these effects may be due to impaired prolifer-
ation and accelerated senescence [67]. Similarly, Fto
deficiency in mice leads to postnatal lethality, growth
retardation, and multiple malformations [62].
The only limited information available about AlkBH5
indicated an essential role in gametogenesis. AlkBH5
expression is highest in primary spermatocytes in the
mouse testes, and its inactivation leads to testis atrophy
and infertility due to failure to enter and proceed through
spermatogenic differentiation [54].
In summary, it is not fully understood how m6A affects
the fate of methylated mRNAs and lncRNAs. While some
evidence suggests that m6A occurrence in mRNA is
inversely correlated to stability [52], it remains unclear
whether specific locations within a transcript dictates
distinct roles in RNA processing. What does become clear
however is that m6A deposition plays essential roles in
mRNA metabolism, and both m6A methylases and
demethylases are crucial during embryonic development
and homeostasis of the central nervous, cardiovascular
and reproductive systems. Furthermore, aberrant m6A
methylation pathways are linked to a range of human
diseases including infertility, obesity as well as develop-
mental and neurological disorders.
Conclusions and future directions
In only a couple years, our understanding about RNA
methylation pathways advanced with remarkable speed
and the importance of RNA methylation and its role in
human diseases is now widely recognized. However, the
precise molecular pathways and cellular processeswww.sciencedirect.com regulated by these modifications are still largely unclear.
Furthermore, we only described current advances on m5C
and m6A methylation, but a large number of other intri-
guing chemical modifications exist in RNAs. Thus, our
current knowledge only scratches the surface of the many
roles of post-transcriptional modifications in modulating
transcriptional and translational processes.
Further advances in the field will rely on the develop-
ment of new system-wide strategies to first, reliably
detect m5C in mRNA or other low abundant RNAs,
second, map m6A at single nucleotide resolution and
third, to identify other RNA modifications. To fully
understand the biological roles of RNA methylation, it
will be required to identify all RNA methylases, de-
methylases, the regulatory pathways that control their
activity and their specific RNA targets. A major goal will
be to dissect the precise mechanisms how RNA modifi-
cations affect global and specific protein production.
Indeed, a modest correlation between cellular mRNA
and protein levels highlights the importance post-tran-
scriptional and post-translational regulatory pathways.
Ultimately, by understanding fundamental aspects of
RNA modification biology we will be able to develop
selective and specific small-molecule inhibitors to modu-
late RNA methylation levels. Such discoveries may well
lead to the identification of novel therapeutic strategies to
treat complex diseases including developmental and
neurological disorders, obesity or cancer.
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